Difference between revisions of "Wang R, et al. Proc. Natl Acad. Sci. USA (2018) cited as Ref 198 in DOI: 10.1038/s41392-020-0110-5 (Q9461)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Proc. Natl Acad. Sci. USA, #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Page(s) (P105): E10127-E10136, #quickstatements; #temporary_batch_1590074839150) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Property / Volume | |||
| + | 115 | ||
| Property / Volume: 115 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway (English) | ||
| Property / title: iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | E10127-E10136 | ||
| Property / Page(s): E10127-E10136 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:33, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wang R, et al. Proc. Natl Acad. Sci. USA (2018) cited as Ref 198 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wang R
0 references
2018
0 references
Proc. Natl Acad. Sci. USA
0 references
115
0 references
iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway (English)
0 references
E10127-E10136
0 references
